Search Results - "Hoban, Daryl"

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent by Zhanel, George G., Cheung, Doris, Adam, Heather, Zelenitsky, Sheryl, Golden, Alyssa, Schweizer, Frank, Gorityala, Bala, Lagacé-Wiens, Philippe R. S., Walkty, Andrew, Gin, Alfred S., Hoban, Daryl J., Karlowsky, James A.

“…Eravacycline is an investigational, synthetic fluorocycline antibacterial agent that is structurally similar to tigecycline with two modifications to the…”
Get full text

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations by Zhanel, George G., Lawrence, Courtney K., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Zhanel, Michael, Lagacé-Wiens, Philippe R. S., Walkty, Andrew, Denisuik, Andrew, Golden, Alyssa, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam,…”
Get full text

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii by Lob, Sibylle H, Hoban, Daryl J, Sahm, Daniel F, Badal, Robert E

“…Highlights • Acinetobacter baumannii susceptibility varied by geographic region but was low everywhere. • Resistance increased over time in several regions. •…”
Get full text

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014 by Lob, Sibylle H, Nicolle, Lindsay E, Hoban, Daryl J, Kazmierczak, Krystyna M, Badal, Robert E, Sahm, Daniel F

“…Abstract Increasing antimicrobial resistance in urinary tract infections (UTI) is a concern. To evaluate resistance trends, 3498 Escherichia coli UTI isolates…”
Get full text

Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination by Zhanel, George G., Lawson, Christopher D., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Lagacé-Wiens, Philippe R. S., Denisuik, Andrew, Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and…”
Get full text

Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli by Zhanel, George G., Chung, Phillip, Adam, Heather, Zelenitsky, Sheryl, Denisuik, Andrew, Schweizer, Frank, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Gin, Alfred S., Walkty, Andrew, Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Ceftolozane is a novel cephalosporin currently being developed with the β-lactamase inhibitor tazobactam for the treatment of complicated urinary tract…”
Get full text

Global incidence of carbapenemase-producing Escherichia coli ST131 by Peirano, Gisele, Bradford, Patricia A, Kazmierczak, Krystyna M, Badal, Robert E, Hackel, Meredith, Hoban, Daryl J, Pitout, Johann D D

“…We characterized Escherichia coli ST131 isolates among 116 carbapenemase-producing strains. Of isolates from 16 countries collected during 2008-2013, 35%…”
Get full text

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 by HAWSER, Stephen P, BOUCHILLON, Samuel K, HOBAN, Daryl J, BADAL, Robert E, HSUEH, Po-Ren, PATERSON, David L

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011 by Bouchillon, Sam K., MD, Badal, Robert E., BS, Hoban, Daryl J., PhD, FCCM, D(ABMM), F(AAM), Hawser, Stephen P., PhD

“…Abstract Background The Study for Monitoring Antimicrobial Resistance Trends is an ongoing global surveillance program that has monitored the susceptibilities…”
Get full text

Comparative review of the carbapenems by ZHANEL, George G, WIEBE, Ryan, DILAY, Leanne, THOMSON, Kristjan, RUBINSTEIN, Ethan, HOBAN, Daryl J, NOREDDIN, Ayman M, KARIOWSKY, James A

“…The carbapenems are beta-lactam antimicrobial agents with an exceptionally broad spectrum of activity. Older carbapenems, such as imipenem, were often…”
Get full text

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens by Zhanel, George G., Love, Riley, Adam, Heather, Golden, Alyssa, Zelenitsky, Sheryl, Schweizer, Frank, Gorityala, Bala, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Walkty, Andrew, Gin, Alfred S., Gilmour, Matthew, Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

“…Tedizolid phosphate is a novel oxazolidinone prodrug (converted to the active form tedizolid by phosphatases in vivo) that has been developed and recently…”
Get full text

Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015 by Karlowsky, James A, Hoban, Daryl J, Hackel, Meredith A, Lob, Sibylle H, Sahm, Daniel F

“…Gram-negative ESKAPE pathogens (Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) are responsible for increases in…”
Get full text

Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13 by Golden, Alyssa R, Rosenthal, Margot, Fultz, Ben, Nichol, Kimberly A, Adam, Heather J, Gilmour, Matthew W, Baxter, Melanie R, Hoban, Daryl J, Karlowsky, James A, Zhanel, George G

“…The goal of this study was to characterize Streptococcus pneumoniae demonstrating MDR (resistant to three or more antimicrobial classes) or XDR (resistant to…”
Get full text

Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15 by Adam, Heather J, Golden, Alyssa R, Karlowsky, James A, Baxter, Melanie R, Nichol, Kim A, Martin, Irene, Demczuk, Walter, Mulvey, Michael R, Gilmour, Matthew W, Hoban, Daryl J, Zhanel, George G

“…This study assessed MDR invasive isolates of Streptococcus pneumoniae, in relation to serotype evolution in Canada between 2011 and 2015 as part of the annual…”
Get full text

Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016 by Denisuik, Andrew J, Karlowsky, James A, Adam, Heather J, Baxter, Melanie R, Lagacé-Wiens, Philippe R S, Mulvey, Michael R, Hoban, Daryl J, Zhanel, George G

“…To assess the prevalence, antimicrobial susceptibilities and molecular characteristics of ESBL-producing Escherichia coli and Klebsiella pneumoniae infecting…”
Get full text

Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region by Hsueh, Po-Ren, Hoban, Daryl J, Carmeli, Yehuda, Chen, Shey-Ying, Desikan, Sunita, Alejandria, Marissa, Ko, Wen-Chien, Binh, Tran Quang

“…Summary Urinary tract infections (UTIs) are among the most prevalent infectious diseases in the general population. They cause a substantial financial burden…”
Get full text

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008) by ZHANEL, George G, DECORBY, Melanie, KARLOWSKY, James A, WALKTY, Andrew, SCHWEIZER, Frank, JOHNSON, Jack, ADAM, Heather, MULVEY, Michael R, MCCRACKEN, Melissa, LAGACE-WIENS, Philippe, NICHOL, Kimberly A, WIERZBOWSKI, Aleksandra, BAUDRY, Patricia J, TAILOR, Franil

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study by Denisuik, Andrew J, Garbutt, Lauren A, Golden, Alyssa R, Adam, Heather J, Baxter, Melanie, Nichol, Kimberly A, Lagacé-Wiens, Philippe, Walkty, Andrew J, Karlowsky, James A, Hoban, Daryl J, Mulvey, Michael R, Zhanel, George G

“…Abstract Objectives To describe the microbiology and antimicrobial resistance patterns of cultured samples acquired from Canadian ICUs. Methods From 2007 to…”
Get full text

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11 by Denisuik, Andrew J, Lagacé-Wiens, Philippe R S, Pitout, Johann D, Mulvey, Michael R, Simner, Patricia J, Tailor, Franil, Karlowsky, James A, Hoban, Daryl J, Adam, Heather J, Zhanel, George G

“…To assess the proportion of Escherichia coli and Klebsiella pneumoniae from Canadian hospitals that produce extended-spectrum β-lactamases (ESBLs), AmpC…”
Get full text

New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin by Zhanel, George G., Calic, Divna, Schweizer, Frank, Zelenitsky, Sheryl, Adam, Heather, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Karlowsky, James A.

“…Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by…”
Get full text